Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof
Reexamination Certificate
2007-02-06
2007-02-06
Gambel, Phillip (Department: 1644)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Monoclonal antibody or fragment thereof
C424S130100, C424S133100, C424S141100, C424S143100, C424S144100, C424S173100, C530S387100, C530S387300, C530S388100, C530S388200, C530S388220, C530S388700, C530S388730
Reexamination Certificate
active
09773866
ABSTRACT:
Disclosed are methods of inducing maturation of antigen presenting cells and cytotoxic T lymphocyte responses utilizing agonist anti-CD40 antibodies that do not block the binding of CD40L to CD40.
REFERENCES:
patent: 4946778 (1990-08-01), Ladner et al.
patent: 5225539 (1993-07-01), Winter
patent: 5534254 (1996-07-01), Huston et al.
patent: 5674492 (1997-10-01), Armitage et al.
patent: 5723322 (1998-03-01), Guettler et al.
patent: 5801227 (1998-09-01), Fanslow, III et al.
patent: 6106835 (2000-08-01), Chang et al.
patent: 6132992 (2000-10-01), Ledbetter et al.
patent: 6497876 (2002-12-01), Maraskovsky et al.
patent: 2003/0022860 (2003-01-01), Melief et al.
patent: 98/01873 (1998-11-01), None
patent: WO 99/61065 (1999-12-01), None
patent: WO 02/11763 (2002-02-01), None
Ngo et al. In The Protein Folding Problem and Tertrary Structure Prediction, 1994, Merz et al. (ed.) Birkhauser Boston, MA. pp. 433, 492-495.
Skolnick et al. Trends in Bio Tech. 18: 34-39 (2000).
Kuntz Science 257: 1078-1082 1992.
Caux et al. Research in Immunology 145: 235-239 (1994).
Zhou et al. Hybridoma 18: 471-478 (1999).
Katira et al. in Lenkocyte Typing V, Schlossman (ed) Oxford University Press Oxford 1995, p. 554.
Heath et al. Eur. J. Immunol. 24: 1828-1834 (1994).
Guerder et al., “A fail-safe mechanism for maintaining self-tolerance”,J. Exp. Med.176(2):553-564 (1992).
Bennett, S.R.M., et al., “Help for Cytotoxic T-Cell Responses is Mediated By CD40 Signaling”,Nature393:478-480 (1998).
Schoenberger, S.P. et al., “T-Cell Help for Cytotoxic T-Lymphocytes is Mediated by CD40-CD40L Interactions”,Nature393:480-483 (1998).
Armitage, R.J., “Tumor necrosis factor receptor superfamily members and their ligands”,Curr. Opin. Immunol.6(3):407-13 (1994).
Alderson, et al., “CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40”,.J. Exp. Med.178(2):669-674 (1993).
Caux, et al., “B70/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells”,J Exp Med.180(5):1841-1847 (1994).
Riechmann, L., et al., “Reshaping Human Antibodies for Therapy”,Nature332: 323-327(1988).
Evans, M. J., et al., “Rapid Expression of an Anti-Human C5 Chimeric Fab Utilizing a Vector That Replicates in COS and 293 Cells”,J. Immunol. Meth.184:123-138 (1995).
Tang, A. et al., “Suppression of Murine Allergic Contact Dermatitis by CTLA41g: Tolerance Induction of Th2 Responses Requires Additional Blockade of CD-40 Ligand”,J. Immunol.157:117-125 (1996).
Ridge, J. P. et al., “A Conditioned Dendritic Cell Can Be a Temporal Bridge Between a CD4+ T-Helper and a T-Killer Cell”,Nature393:474-477 (1998).
Caux, C. et al., “Activation of human dendritic cells through CD40 cross-linking” J Exp Med. 180(4):1263-1272 (1994).
Bjorck et al. “Antibodies to distinct epitopes on the CD40 molecule co-operate in stimulation and can be used for the detection of soluble CD40.”Immunology. Nov. 1994;83(3):430-7.
Heath et al. “Monoclonal antibodies to murine CD40 define two distinct functional epitopes.”Eur. J. Immunol. Aug. 1994;24(8):1828-34.
Holder et al. “Suppression of apoptosis in normal and neoplastic human B lymphocytes by CD40 ligand is independent of Bc1-2 induction.”Eur. J. Immunol. Sep. 1993;23(9):2368-71.
Pellat-Deceunynck et al. “CD11a-CD18 and CD102 interactions mediate human myeloma cell growth arrest induced by CD40 stimulation.”Cancer Res. Apr. 15, 1996;56(8):1909-16.
Schwabe et al. “Modulation of soluble CD40 ligand bioactivity with anti-CD40 antibodies.”Hybridoma. Jun. 1997;16(3):217-26.
Valle et al. “Activation of human B lymphocytes through CD40 and interleukin 4.”Eur. J. Immunol. Aug. 1989;19(8):1463-7.
Jeffrey A. Ledbetter, et al.; “Agonistic Activity Of A CD40-Specific Single-Chain Fv Constructed From The Variable Regions Of mAb G28-5”;Critical Reviews In Immunology, vol. 17, Issue 1, pp. 427-435; 1997.
Zhao-hua Zhou et al.; “An Agonist Anti-Human CD40 Monoclonal Antibody that Induces Dendritic Cell Formation And Maturation And Inhibits Proliferation Of A Myeloma Cell Line”;Hybridoma, vol. 18, no. 6, pp. 471-478; 1999.
Bjorck, P. et al.; “CD40 Antibodies Defining Distinct Epitopes Display Qualitative Differences In Their Induction Of B-Cell Differentiation”;Immunology, Blackwell Scientific Publication, GB, vol. 87, pp. 291-295; 1996, XP002930984 ISSN: 0019-2805.
Challa, A. et al., “Epitope-dependent Synergism And Antagonism Between CD40 Antibodies And Soluble CD40 Ligand For The Regulation Of CD23 Expression And IgE Synthesis In Human B Cells”;Allergy(Copenhagen), vol. 54, no. 6, pp. 576-583; Jun. 1999. XP002276806 ISSN: 0105-4538.
Dullforce, P. et al., “Enhancement Of T Cell-Independent Immune Responses In Vivo By CD40 Antibodies”;Nature Medicine Nature Publishing Co., US, vol. 4, No. 1, pp. 88-91; Jan. 1998. XP009026323 ISSN: 1078-8956.
French, R. et al., “CD40 Antibody Evokes A Cytotoxic T-cell Response That Eradicates Lymphoma And Bypasses T-cell Help”;Nature Medicine, Nature Publishing, CO, US, vol. 5, No. 5, pp. 548-553; May 1999. XP002159390 ISSN: 1078-8956.
de Boer Mark
Res Pieter C. J. M.
Simons Peter J.
Thomas David
Darby & Darby
Gambel Phillip
Pangenetics BV
LandOfFree
Induction of cytotoxic T lymphocyte responses using... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Induction of cytotoxic T lymphocyte responses using..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Induction of cytotoxic T lymphocyte responses using... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3844657